Markets:

Overview

News

Currencies

International

Treasuries

RenovoRx, Inc. - Common Stock (NQ:RNXT)

0.9424 +0.0023 (+0.24%)

Streaming Delayed Price Updated: 9:55 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RenovoRx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations

April 11, 2023

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 03, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 03, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 30, 2023

Via Benzinga

RenovoRx Reports Initial Results From Targeted Treatment For Pancreatic Cancer ↗

January 18, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

March 30, 2023

From RenovoRx, Inc.

Via Business Wire

US Stocks Open Higher; Dow Jumps 150 Points ↗

March 30, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday. Following the market opening Thursday, the Dow traded up 0.48% to 32,874.88 while the NASDAQ rose 0.68%...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 30, 2023

Via Benzinga

RenovoRx Announces Positive New Data from Phase III Clinical Trial Interim Analysis: 60% Survival Benefit and Fewer Side Effects than Systemic Chemotherapy

March 30, 2023

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 29, 2023

Via Benzinga

RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube ↗

March 21, 2023

In the interview, Dr. Michael Pishvaian discussed the trial's potential impact on the oncology community as well as how pancreatic cancer patients are treated.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 09, 2023

Via Benzinga

RenovoRx's Targeted Prostate Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care ↗

March 08, 2023

Via Benzinga

RenovoRx Phase III Open Label TIGeR-PaC Interim Analysis Shows Promising Data That Support Continued Clinical Investigation of RenovoGemTM as a Treatment Option for Locally Advanced Pancreatic Cancer

March 08, 2023

From RenovoRx, Inc.

Via Business Wire

RenovoRx, Inc. Full-year 2022 Results Provide Clues Supporting A Near-Term Catalyst-Fueled Breakout ($RNXT)

March 06, 2023

Via AB Newswire

RenovoRx Reports Full Year 2022 Financial Results and Achievement of Important Phase III Clinical Study Milestone

March 02, 2023

From RenovoRx, Inc.

Via Business Wire

RenovoRx, Inc. Shares Surge 117% YTD As Multiple Catalysts Come Into Focus ($RNXT)

March 02, 2023

Via AB Newswire

RenovoRx to Present at the 35th Annual Roth Conference on March 13, 2023

March 01, 2023

From RenovoRx, Inc.

Via Business Wire

RenovoRx, Inc. Shares Rally As RenovoTAMP Cancer Treatment Platform Continues To Attract Sector Attention ($RNXT)

March 01, 2023

Via AB Newswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 28, 2023

Via Benzinga

RenovoRX's Latest Innovative Technology Creates New Hope for Chemotherapy Patients ↗

February 14, 2023

RenovoRx takes existing chemotherapies and makes them more effective and less invasive at the same time, by being able to concentrate most of the chemotherapy agent on the tumor itself.

Via Talk Markets

RenovoRx to Present at the Sequire Biotechnology Virtual Conference on February 2, 2023

January 25, 2023

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 23, 2023

Via Benzinga

Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 23, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...

Via Benzinga

Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low ↗

January 19, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 19, 2023

Via Benzinga

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 19, 2023

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.

Via Benzinga

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 18, 2023

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...

Via Benzinga

RenovoRx Announces Initial Results in Pharmacokinetic (PK) Substudy: Data on RenovoGem™ Supports Potential for RenovoTAMP® Therapy Platform to Increase Local Gemcitabine (Chemotherapy) Delivery and Decrease Side Effects of Pancreatic Cancer Treatment

January 18, 2023

From RenovoRx, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.